JP2024527034A5 - - Google Patents

Info

Publication number
JP2024527034A5
JP2024527034A5 JP2024504874A JP2024504874A JP2024527034A5 JP 2024527034 A5 JP2024527034 A5 JP 2024527034A5 JP 2024504874 A JP2024504874 A JP 2024504874A JP 2024504874 A JP2024504874 A JP 2024504874A JP 2024527034 A5 JP2024527034 A5 JP 2024527034A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
agent according
patient
effective amount
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504874A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527034A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038370 external-priority patent/WO2023009537A1/en
Publication of JP2024527034A publication Critical patent/JP2024527034A/ja
Publication of JP2024527034A5 publication Critical patent/JP2024527034A5/ja
Pending legal-status Critical Current

Links

JP2024504874A 2021-07-26 2022-07-26 若年性左心低形成症候群の治療における間葉系幹細胞の使用 Pending JP2024527034A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163203519P 2021-07-26 2021-07-26
US63/203,519 2021-07-26
PCT/US2022/038370 WO2023009537A1 (en) 2021-07-26 2022-07-26 Use of mesenchymal stem cells in treatment of juvenile hypoplastic left heart syndrome

Publications (2)

Publication Number Publication Date
JP2024527034A JP2024527034A (ja) 2024-07-19
JP2024527034A5 true JP2024527034A5 (https=) 2025-08-05

Family

ID=83049982

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504874A Pending JP2024527034A (ja) 2021-07-26 2022-07-26 若年性左心低形成症候群の治療における間葉系幹細胞の使用

Country Status (9)

Country Link
US (1) US20240350549A1 (https=)
EP (1) EP4376950A1 (https=)
JP (1) JP2024527034A (https=)
KR (1) KR20240040776A (https=)
CN (1) CN117999082A (https=)
AU (1) AU2022316959A1 (https=)
CA (1) CA3227475A1 (https=)
TW (1) TW202321437A (https=)
WO (1) WO2023009537A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025062365A1 (en) * 2023-09-22 2025-03-27 Mesoblast International Sárl Mesenchymal lineage precursor or stem cells (mlpscs) for use in methods of treating congenital heart disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180105705A (ko) 2016-02-04 2018-09-28 롱에버론 엘엘씨 백신 보조제로서의 중간엽 줄기 세포 및 그의 사용 방법
JP7276664B2 (ja) 2016-11-11 2023-05-18 ロングエバーオン インコーポレイテッド 細胞性及び体液性免疫を達成するためのヒト間葉系幹細胞を使用する方法
SG11201912209UA (en) 2017-06-19 2020-01-30 Longeveron Llc Treatment of sexual dysfunction and improvement in sexual quality of life
AU2020356193A1 (en) * 2019-09-24 2022-05-19 Children's Hospital Of Philadelphia Methods of improving exercise performance, single ventricular performance, and myocardial performance index (MPI) in single ventricle heart disease, using udenafil compositions

Similar Documents

Publication Publication Date Title
RU2010114024A (ru) Применение гонадорелина в качестве терапевтического средства
CN118121634B (zh) IMRC-Exo在制备减轻心脏骤停复苏后多器官损伤药物中的应用及药物
RU2010114050A (ru) Применение пептида рецептора il-1 индивидуально или в комбинации с октадециловым эфиром d-ala-gln в качестве терапевтического средства
LILLEHEI et al. Complete anatomical correction of the tetralogy of fallot defects: Report of a successful surgical case
CN103816280A (zh) 一种治疗心肌梗死的中药组合物及其应用
JP2024527034A5 (https=)
CN110462023A (zh) 作为有效成分包括组蛋白去乙酰化酶抑制剂和激活因子的干细胞活性促进用组合物
CN108472417A (zh) 用于生成、使用和递送活化的干细胞的方法和系统
ES3017482T3 (en) Treatments for heart failure and cardiac ischaemic reperfusion injury
LIND et al. The dynamics of the heart in complete AV block: An angiocardiographic study
Riemenschneider et al. Maturational changes in myocardial pump performance in newborn lambs
Bilewska et al. Stem cell therapy for single ventricle congenital heart disease–Current state and future directions
JP2005206544A (ja) 筋肉再生剤
CN100356952C (zh) 一种治疗心力衰竭的中药组合物及其口服制剂
CN110448625B (zh) 一种治疗缺氧性肾损伤疾病的中药组合物、制备方法及其应用
Soroff et al. Treatment of power failure by means of mechanical assistance
CN113425731B (zh) 一种增效干细胞治疗心梗的药物及其应用
Birtwell et al. Synchronous assisted circulation
MS et al. Case of dilated cardiomyopathy after cellular therapy
Ruf et al. Transient complete atrioventricular block after percutaneous pulmonary valve implantation
Okpala et al. Mesenchymal Stromal Cells Used for Cellular Cardiomyoplasty to Treat Myocardial Infarction and Heart Failure
Kursova et al. Allogenic cardiomyoblasts raised from human mesenchymal stem cells in the therapy of radiation cardiomyopathy and pericarditis: case report
CN102091062A (zh) 一种采取吸入给药紫杉醇治疗肺癌的方法
Birtwell et al. Synchronous pressure assist-counterpulsation
RU2698631C2 (ru) Способ лечения острой левожелудочковой сердечно-сосудистой недостаточности при инфаркте миокарда